Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study

Background. Primaquine is used to eradicate latent Plasmodium vivax parasite from liver, with administration of standard dose daily up to 14 days. We studied efficacy, safety, and tolerability of sustained release (SR) formulation of primaquine in comparison with conventional primaquine in preventin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareek, Anil, Chandurkar, Nitin, Gogtay, Nithya, Deshpande, Alaka, Kakrani, Arjun, Kaneria, Mala, Karmakar, Partha, Jain, Arvind, Kochar, Dhanpat, Chogle, Arun, Ray, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558454/
https://www.ncbi.nlm.nih.gov/pubmed/26366319
http://dx.doi.org/10.1155/2015/579864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558454/
https://www.ncbi.nlm.nih.gov/pubmed/26366319
http://dx.doi.org/10.1155/2015/579864

Ejemplares similares